Concord Wealth Partners’s LeMaitre Vascular LMAT Stock Holding History

Concord Wealth Partners’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.85K	Buy	+61	New	+$6.25K	﹤0.01%	635
2026 Q1	–	Sell	-61	Closed	-$4.95K	–	536
2025 Q4	$4.95K	Sell	61 -8	-12%	-$689	﹤0.01%	623
2025 Q3	$6.04K	Hold	69	–	–	﹤0.01%	590
2025 Q2	$5.73K	Buy	69 +10	+17%	+$836	﹤0.01%	612
2025 Q1	$4.95K	Hold	59	–	–	﹤0.01%	586
2024 Q4	$5.44K	Hold	59	–	–	﹤0.01%	595
2024 Q3	$5.48K	Buy	59 +8	+16%	+$693	﹤0.01%	623
2024 Q2	$4.2K	Hold	51	–	–	﹤0.01%	592
2024 Q1	$3.38K	Buy	+51	New	+$3.15K	﹤0.01%	698

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Concord Wealth Partners's LMAT Position: Q2 2026 in Review

Concord Wealth Partners opened a new position in LeMaitre Vascular (LMAT) in Q2 2026: 61 shares worth $5.85K. The stake represents ﹤0.01% of the portfolio and ranks #635 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in LMAT as recently as Q4 2025.

Concord Wealth Partners first reported a position in LMAT in Q1 2024 and has held it in 9 quarters since. The position peaked at $6.04K in Q3 2025. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Concord Wealth Partners held 61 shares of LeMaitre Vascular worth $5.85K as of Q2 2026.
LeMaitre Vascular was a new Concord Wealth Partners position in Q2 2026.
LeMaitre Vascular made up ﹤0.01% of Concord Wealth Partners's portfolio in Q2 2026, its #635 holding.
Concord Wealth Partners first reported a position in LeMaitre Vascular in Q1 2024 and has held it in 9 quarters since.
Concord Wealth Partners's LeMaitre Vascular position peaked at $6.04K in Q3 2025.
327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.